0001815624-25-000001.txt : 20250204 0001815624-25-000001.hdr.sgml : 20250204 20250204160312 ACCESSION NUMBER: 0001815624-25-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20250204 DATE AS OF CHANGE: 20250204 EFFECTIVENESS DATE: 20250204 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GelMEDIX, Inc. CENTRAL INDEX KEY: 0001815624 ORGANIZATION NAME: IRS NUMBER: 881188838 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-537321 FILM NUMBER: 25588058 BUSINESS ADDRESS: STREET 1: 90 BRIDGE STREET CITY: NEWTON STATE: MA ZIP: 02458 BUSINESS PHONE: 617-500-3455 MAIL ADDRESS: STREET 1: 90 BRIDGE STREET CITY: NEWTON STATE: MA ZIP: 02458 D 1 primary_doc.xml X0708 D LIVE 0001815624 GelMEDIX, Inc. 238 Main Street, Fifth Floor Cambridge MA MASSACHUSETTS 02142 941-228-8711 DELAWARE None None Corporation true 2020 Max Cotler c/o GelMEDIX, Inc. 238 Main Street, Fifth Floor Cambridge MA MASSACHUSETTS 02142 Executive Officer Nasim Annabi c/o GelMEDIX, Inc. 238 Main Street, Fifth Floor Cambridge MA MASSACHUSETTS 02142 Director Reza Dana c/o GelMEDIX, Inc. 238 Main Street, Fifth Floor Cambridge MA MASSACHUSETTS 02142 Director Michael Cima c/o GelMEDIX, Inc. 238 Main Street, Fifth Floor Cambridge MA MASSACHUSETTS 02142 Director Parinaz Motamedy c/o GelMEDIX, Inc. 238 Main Street, Fifth Floor Cambridge MA MASSACHUSETTS 02142 Director Biotechnology Decline to Disclose 06b false 2025-01-24 false true true false 0 4000000 1000000 3000000 false 2 0 0 0 The proceeds are available to fund general working capital requirements; as of the date of this filing no detailed operating budget has been adopted; and no proceeds have been or are proposed to be used for payments of compensation. false GelMEDIX, Inc. /s/ Max Cotler Max Cotler President 2025-01-30